Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.05.2023 | Case report

Fentanyl/oxycodone

Exacerbation of chronic spontaneous urticaria: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bakhtiar MF, et al. Incremental drug provocation test under high dose antihistamines coverage in difficult to control chronic spontaneous urticaria: A report of two cases. Allergy 78 (Suppl. 111): 712 abstr. 100171, Feb 2023. Available from: URL: http://doi.org/10.1111/all.15616 Bakhtiar MF, et al. Incremental drug provocation test under high dose antihistamines coverage in difficult to control chronic spontaneous urticaria: A report of two cases. Allergy 78 (Suppl. 111): 712 abstr. 100171, Feb 2023. Available from: URL: http://​doi.​org/​10.​1111/​all.​15616
Metadaten
Titel
Fentanyl/oxycodone
Exacerbation of chronic spontaneous urticaria: case report
Publikationsdatum
01.05.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38844-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Rituximab

Case report

Fingolimod

Case report

Tozinameran

Case report

Ajmaline

Case report

Selexipag